Inactive

This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. The National Institute of Health (NIH), Clinical Center (CC)... This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. The National Institute of Health (NIH), Clinical Center (CC), intends to solicit a quote and enter into firm-fixed price to purchase Phoenix WinNonlin Validation Suite, with CERTARA USA INC. The Clinical Center requires: • A pharmacokinetic modeling platform, WinNonlin® • A validation suite to verify integrity of data from WinNonlin® for FDA submissions • A CDISC Navigator to ensure data is in FDA format for submissions This acquisition is being conducted using policies unique to the acquisition of commercial items prescribed in FAR Part 12, in conjunction with the policies and procedures for the competition requirements of Part 6. Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government. Comments to this announcement, referencing this posting number, may be submitted to the CC, Office of Purchasing and Contracts, prior to the closing date, May 01, 2023 at 12:00 PM EST specified in this announcement, electronically to the attention of Noelle DeCenzo, Contract Specialist, Noelle.decenzo@nih.gov by the due date and time marked in this notice.